Controlled Drugs: Learning from Incidents Issue 8

Issue 8 of the bulletin: Controlled Drugs: Learning from Incidents, produced by NECS on behalf of NHS England is now available.

Issue 8 covers:
• Reporting incidents
• Post-dated CD prescriptions dispensed too early
• Patients with protected addresses
• Midazolam injection for palliative care
• What can happen when things go wrong when prescribing for chronic pain

Can patients on levothyroxine take sea kelp?

Medicines Q&A from NHS Specialist Pharmacy Services:

The term kelp can refer to a variety of brown sea weeds. The iodine content in kelp products varies considerably, even between products of the same brand. Hypo- and hyperthyroidism disorders have been attributed to the use of kelp products. UK and American resources caution or advise against the concurrent use of levothyroxine and kelp products. Kelp products should be avoided in patients suffering from thyroid disorders regardless of whether they are taking thyroid supplementation.

Which medicines could cause problems for patients during a heatwave?

This Q&A from NHS Specialist Pharmacy Service discusses the issues that need to be considered for patients during a heatwave, including the storage and adverse effects of medicines.

Comparative table of low molecular weight heparins

In light of current shortage of enoxaparin injection (all strengths), NHS Specialist Pharmacy Services have published a table of licensed low molecular weight heparins to compare/contrast key prescribing parameters.

NICE Bites: Eating Disorders, recognition & treatment

NICE Bites: Eating Disorders, recognition & treatment This guideline, produced by SPS, covers recognition and treatment of eating disorders including […]

Public Health England Vaccine Update Issue – Edition 264 – June 2017

Public Health England Vaccine Update Issue – Edition 264 – June 2017 The June edition of Vaccine Update is now available. […]

MHRA Drug Safety Update June 2017

MHRA Drug Safety Update June 2017 A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (vol 10, […]

Discontinuation of Protelos (strontium ranelate) 2g granules for oral suspension

Discontinuation of Protelos (strontium ranelate) 2g granules for oral suspension Servier will cease production and distribution of strontium ranelate at […]

NICE Bites – Cerebral palsy in under 25’s

NICE Bites – Cerebral palsy in under 25’s NICE Bites No 97 May 2017 includes one topic: Cerebral palsy in […]